"CerpassRx Purchased by LucyRx: Amplifies Clinical Proficiency and Broader Offering of Advanced Healthcare Services"
In a significant move, the fast-scaling next-generation pharmacy benefits manager, LucyRx, has announced a definitive agreement to bring CerpassRx into the LucyRx organization. This partnership, set to be formalized in mid-2025, combines LucyRx's technology-driven clinical model with CerpassRx's expertise in cost containment and high-touch service, creating a more impactful PBM solution.
Smarter Cost Containment
The synergy between the two companies promises smarter cost containment. CerpassRx's proprietary cost-saving strategies, flexible formulary designs, and tailored clinical programs will be layered onto LucyRx's transparent pricing and proprietary Formulary Marketplace. This integration is expected to drive down prescription costs effectively while maintaining clinical rigor and measurable outcomes.
Stronger Member Support
The partnership also strengthens member support. LucyRx's personalized clinical guidance through its Care Guides will integrate with CerpassRx's service-first, high-touch model, creating a more seamless and responsive experience for members. This enhanced support is particularly beneficial in high-impact areas such as GLP-1 therapies and women's health.
Scalable Innovation
The combination of LucyRx's AI-powered insights and connected specialty care network with CerpassRx's rapid implementation capabilities and client partnership approach will drive scalable innovation. This integration allows the PBM to deliver personalized care at scale, improve member engagement, and incorporate cutting-edge clinical programs that adapt to evolving market demands.
A Powerhouse PBM
The merger creates a performance-driven, clinically forward, and transparent PBM powerhouse. This new entity is designed to serve a broad range of clients—from mid-market health plans to large self-funded employers—with a technology-first, partner-centric approach that aims to simplify pharmacy benefit management while improving outcomes and lowering costs.
The partnership also aligns with recognized industry innovation, as LucyRx's CEO recently earned an innovator award for contributions to advancing PBM practices through technology and care.
A National PBM Platform
Together, LucyRx and CerpassRx form a national PBM platform that is performance-driven, clinically forward, and relentlessly focused on serving clients and members with clarity and accountability. The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in Q3 2025.
Continued Collaboration with Nomi Health
Nomi Health, a direct healthcare company that is rebuilding healthcare through its integrated platform, continues to work with LucyRx to support their shared clients and build on current partnership efforts to reduce pharmacy costs for both employers and their members. There will be no changes to service, support, or operations as a result of this agreement for clients and members.
For media inquiries, Tricia Bancroft can be reached at LucyRx, while Rebeca Damico can be reached at Nomi Health. LucyRx partners with more than 60,000 pharmacies and serves over 1,200 clients nationwide. CerpassRx, a division of Nomi Health, is a leading, full-service PBM based in Dallas-Fort Worth, Texas.
[1] LucyRx Press Release, "LucyRx and CerpassRx Announce Strategic Partnership to Deliver Smarter Care, Stronger Savings, and a Seamless Experience for Clients and Members," [date], [URL] [2] Nomi Health Press Release, "Nomi Health and LucyRx Partner to Reduce Pharmacy Costs for Employers and Members," [date], [URL] [3] LucyRx Investor Presentation, "LucyRx and CerpassRx: A Powerful Combination," [date], [URL] [4] PBM Journal, "LucyRx CEO Recognized as Innovator in PBM Practices," [date], [URL]
- The partnership between LucyRx and CerpassRx aims to deliver smarter cost containment by integrating CerpassRx's cost-saving strategies with LucyRx's transparent pricing and Formulary Marketplace.
- The combination of LucyRx's AI-powered insights and connected specialty care network with CerpassRx's rapid implementation capabilities and client partnership approach will drive scalable innovation, improving member engagement and lowering costs.
- The merger creates a performance-driven, clinically forward, and transparent PBM powerhouse, designed to serve a broad range of clients and aiming to simplify pharmacy benefit management while improving outcomes and lowering costs.
- In addition to its partnership with LucyRx, CerpassRx, a division of Nomi Health, continues to work with Nomi Health to reduce pharmacy costs for employers and their members, with no changes to service or operations.
- This partnership between LucyRx and CerpassRx forms a national PBM platform that is performance-driven, clinically forward, and relentlessly focused on serving clients and members with clarity and accountability, subject to regulatory approvals and customary closing conditions.
